Chart Showing XBI breakdown 9-3-20 thru 9-4-20Broader Market ConditionsBetween yesterday and today the broader markets have been in a free-fall and the biotech sector was not immune despite missing … [Read more...] about Volatility Update 9-4-20
DarioHealth (Nasdaq: DRIO) Gains Traction on $28.6M Private Placement, New Contract Prospects, and M&A speculation
In my last article, following the 38th Annual JP Morgan Healthcare Conference, I presented my investment thesis for DarioHealth (Nasdaq: DRIO) as a growth play in the nascent Digital Therapeutics … [Read more...] about DarioHealth (Nasdaq: DRIO) Gains Traction on $28.6M Private Placement, New Contract Prospects, and M&A speculation
BioCryst Pharmaceuticals (Nasdaq: BCRX): Embarrassment of Riches
Founded in 1986 BioCryst Pharmaceuticals (BCRX) specializes in the development of novel, oral, small molecules that inhibit enzymes playing a key role in the biological pathway of rare diseases. … [Read more...] about BioCryst Pharmaceuticals (Nasdaq: BCRX): Embarrassment of Riches
La Jolla Pharmaceuticals (Nasdaq: LJPC): An Assessment of The Tetraphase Acquisition
For the past 8-months now our team has been long La Jolla Pharmaceuticals (Nasdaq: LJPC) calling for a substantial upside in the stock price. At times our thesis has played out such as with the … [Read more...] about La Jolla Pharmaceuticals (Nasdaq: LJPC): An Assessment of The Tetraphase Acquisition
DelMar Pharmaceuticals (NASDAQ: DMPI): A New Beginning
For the past 6-months our team at MS Money Moves has been following the story of DelMar Pharmaceuticals (NASDAQ: DMPI) in an effort to educate and inform the investment community. During this time, we … [Read more...] about DelMar Pharmaceuticals (NASDAQ: DMPI): A New Beginning
LJPC and BCRX Updates: 5/27/20
5/27/20 was the worst day for our team since March 13th when almost every stock on the market was halted due to volatility. Our two largest positions, La Jolla Pharmaceuticals (Nasdaq: LJPC) and … [Read more...] about LJPC and BCRX Updates: 5/27/20
DelMar Pharmaceutical (NASDAQ: DMPI) Remains On Track Despite COVID-19 Crisis
Recap: Since November of 2019 MS Money Moves has been following DelMar Pharmaceuticals (Nasdaq: DMPI) closely through a number of key value inflection points. In my initial article I … [Read more...] about DelMar Pharmaceutical (NASDAQ: DMPI) Remains On Track Despite COVID-19 Crisis
How To Day Trade Stocks
Several of our community members have asked us about how to go about day-trading stocks. In this article I will outline our day-trading strategy using BCRX as an example. What To Look … [Read more...] about How To Day Trade Stocks
Quarterly Update, 1Q20: LJPC
In this article series I go over our core investments, their investment thesis, and new developments during the First Quarter of 2020 (1/1/20 to 3/31/20) starting with LJPC. La Jolla … [Read more...] about Quarterly Update, 1Q20: LJPC
Daily Trade Insights
Updated 10/18/20Red = High risk, most speculative play Yellow = Medium riskGreen = Lower risk, supported by stronger fundamentalsLet us know if you have any questions/feedback! … [Read more...] about Daily Trade Insights
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Portuguese
Russian
Spanish